Evoke Pharma to Participate in the Oppenheimer & Co. Specialty Pharmaceuticals Conference Read more about Evoke Pharma to Participate in the Oppenheimer & Co. Specialty Pharmaceuticals Conference
Evoke Pharma Completes Dosing for Gimoti™ Comparative Exposure Pharmacokinetic Study Read more about Evoke Pharma Completes Dosing for Gimoti™ Comparative Exposure Pharmacokinetic Study
Evoke Pharma to Present at the 19th Annual Rodman & Renshaw Global Investment Conference Read more about Evoke Pharma to Present at the 19th Annual Rodman & Renshaw Global Investment Conference
Evoke Pharma Reports Second Quarter 2017 Results and Highlights Read more about Evoke Pharma Reports Second Quarter 2017 Results and Highlights
Evoke Pharma Initiates Comparative Exposure Pharmacokinetic Study for Gimoti™ Read more about Evoke Pharma Initiates Comparative Exposure Pharmacokinetic Study for Gimoti™
Evoke Pharma Schedules Conference Call and Webcast for Second Quarter 2017 Financial Results Read more about Evoke Pharma Schedules Conference Call and Webcast for Second Quarter 2017 Financial Results
Evoke Pharma Enters Agreement with Rho to Submit NDA for Gimoti Read more about Evoke Pharma Enters Agreement with Rho to Submit NDA for Gimoti
Evoke Pharma Reports First Quarter 2017 Results Read more about Evoke Pharma Reports First Quarter 2017 Results
Evoke Pharma Presents Gimoti Efficacy and Safety Data from Phase 3 Trial as Late Breaker at Digestive Disease Week 2017 Read more about Evoke Pharma Presents Gimoti Efficacy and Safety Data from Phase 3 Trial as Late Breaker at Digestive Disease Week 2017
Evoke Pharma Schedules Conference Call and Webcast for First Quarter 2017 Financial Results Read more about Evoke Pharma Schedules Conference Call and Webcast for First Quarter 2017 Financial Results